The Biden administration has announced a significant policy shift regarding access to anti-obesity medications for Medicare and Medicaid patients. This reinterpretation aims to enhance long-term weight...
WASHINGTON — The Biden administration revealed on Tuesday a significant shift in federal policy concerning Medicare and Medicaid, now permitting patients to access anti-obesity medications for...